This article was originally published as: HOSPITAL IN THE HOME (HITH) CARE FOLLOWING AUTOLOGOUS STEM CELL TRANSPLANTATION FOR LYMPHOMA AND MULTIPLE MYELOMA
Original Article Link: Read Original Article
Download PDF: Click Here to Download PDF
Abstract
Background: Advances in outpatient and supportive care and increased pressure on hospital bed usage has led to the investigation of hospital in the home (HITH) management following autologous haematologous stem cell transplantation (AutoHSCT) for patients with multiple myeloma or lymphoma.
Design: The Newcastle Mater Hospital Haematology Unit together with the Mater Acute Care Community Service (MACCS) developed a protocol for HITH care following AutoHSCT.
Outcomes: Clinical outcomes of the protocol were audited: 40% (13) of patients were suitable candidates for HITH care post transplantation. Of these 84.6% (11) were readmitted to the haematology unit within seven days of discharge from hospital.
Conclusion: Our preliminary experience suggests that with adequate infrastructure support and rigorous patient selection this model of care is both safe and feasible.
Authors
- Wendy Johnson
- Ian Kerridge
- Cathie Milton
- Debbie Carr
- Arno Enno
- Louisa Bray
- Angela Booth
Keywords
outpatient, chemotherapy, bone marrow transplant, autologous, hospital in the home (HITH), myeloma, lymphoma
References
References not available for this article.
